1. Home
  2. BLLN vs STNE Comparison

BLLN vs STNE Comparison

Compare BLLN & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BLLN

BillionToOne Inc.

N/A

Current Price

$79.32

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Logo StoneCo Ltd.

STNE

StoneCo Ltd.

HOLD

Current Price

$14.07

Market Cap

3.3B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLLN
STNE
Founded
2016
2012
Country
United States
Cayman Islands
Employees
713
N/A
Industry
Medical Specialities
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.3B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BLLN
STNE
Price
$79.32
$14.07
Analyst Decision
Buy
Strong Buy
Analyst Count
7
7
Target Price
$126.71
$19.07
AVG Volume (30 Days)
281.7K
3.8M
Earning Date
03-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$45.96
$14.84
Revenue Next Year
$30.11
$6.04
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$61.96
$11.39
52 Week High
$138.70
$19.95

Technical Indicators

Market Signals
Indicator
BLLN
STNE
Relative Strength Index (RSI) 49.92 46.93
Support Level $64.99 $13.10
Resistance Level $83.20 $15.93
Average True Range (ATR) 6.62 0.57
MACD 1.22 0.10
Stochastic Oscillator 42.50 45.55

Price Performance

Historical Comparison
BLLN
STNE

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services segment, which includes payments solutions, digital banking, credit, insurance solutions as well as the registry business. In the Software segment solution includes POS/ERP, TEF and QR Code gateways, reconciliation, CRM, OMS, e-commerce platform, engagement tool, ads solution, and marketplace hub. It generates the majority of its revenue from the Financial Services segment.

Share on Social Networks: